Korsana Biosciences, Inc. (KRSA)

Korsana Biosciences, Inc. (KRSA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.5B; returns 1 day -6.3%, 1 week -3.3%, 1 year +110.0%.

Korsana Biosciences, Inc. (NASDAQ: KRSA) is a clinical-stage biotechnology company focused on discovering and developing novel therapeutic antibodies to treat neurodegenerative diseases.

Groups KRSA belongs to

• Recent Reverse Splits
• Biotechnology
• Clinical Stage Biotech
• Neuroscience
• Alzheimer's Disease
• Biopharmaceutical
• Clinical Stage Biopharma
• CNS Disorders
• Clinical Stage
• Antibody Therapeutics
• Monoclonal Antibodies

KRSA financial model: income statement, cash flow and balance sheet